Leann Moore
Family Medicine · New Bern, NCNPI 1659327864
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 307 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,696 and has fallen 98.4% since, to $28 in 2025.
Across 307 payments — averaging $13.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$494
- Novo Nordisk$481
- AstraZeneca$408
- GSK$327
- Amarin Pharma, Inc.$300
- Johnson & Johnson$253
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,247100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 35 | $494 |
| Novo Nordisk | 33 | $481 |
| AstraZeneca | 27 | $408 |
| GSK | 28 | $327 |
| Amarin Pharma, Inc. | 20 | $300 |
| Johnson & Johnson | 24 | $253 |
| Sanofi-aventis U.S. LLC | 20 | $249 |
| Boehringer Ingelheim | 17 | $229 |
| Pfizer | 13 | $195 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $190 |
| Lilly USA, LLC | 11 | $160 |
| Merck | 9 | $136 |
| Hikma Pharmaceuticals USA | 7 | $102 |
| Eisai Inc. | 7 | $101 |
| AbbVie(2 entities) | 6 | $86 |
| Kowa Pharmaceuticals America, Inc. | 6 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $76 |
| Ironwood Pharmaceuticals, Inc | 4 | $64 |
| Esperion Therapeutics, Inc. | 3 | $51 |
| Boston Scientific | 2 | $46 |
| Mylan Specialty L.p. | 3 | $40 |
| EMD Serono, Inc. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Shire North American Group Inc | 1 | $21 |
| Novartis | 1 | $16 |
| Abbott | 1 | $16 |
| Nalpropion Pharmaceuticals LLC | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Philips North America LLC | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,265 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in New Bern
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.